Letters to the Editor
Vol. 5 No. 1 (2026)
Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 15 January 2026
12
Views
3
Downloads
Authors
Dear Editor,
We are pleased to announce the establishment of the first national registry for congenital hematological disorders in Palestine, an initiative designed to improve the diagnosis and management of patients affected by hemophilia, other inherited coagulation disorders, thalassemia, and related hemoglobinopathies...
Downloads
Download data is not yet available.
Citations
.
How to Cite
1.
Candura F, Marchesini E, Forni GL, Gringeri A, Gentilini I, Tricoli M, et al. Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative. Bleeding Thromb Vascul Biol [Internet]. 2026 Jan. 15 [cited 2026 Jan. 20];5(1). Available from: https://www.btvb.org/btvb/article/view/417
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- CO14 | Inflammation and fibrinolysis biomarkers as predictors of cancer risk in healthy subjects: results from the hypercan study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO27 | Intracerebral hemorrhage in hemophilia A and B: a 10-year prospective multicenter study in Italy (2012–2022) , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CS08 | A combination of two rapid immunoassays improves HIT diagnosis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Marco Marietta, Giancarlo Castaman, Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship” , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic, “Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 1 (2025)
- PO09 | Comparison of different aggregometry methods for evaluation of platelet function in patients with myeloproliferative neoplasms , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO12 | Characterisation and real word clinical data of HEM006, a newly formulated intranasal spray desmopressin (DDAVP) to address a global treatment gap , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO15 | Venous thromboembolism risk associated with midline catheters and peripherally inserted central catheters: a systematic review and meta-analysis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Valerio De Stefano, In memoriam of Professor Bruno Bizzi (1927-2023) , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 4 (2023)
- Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati, It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
You may also start an advanced similarity search for this article.
